The prevalence of obstructive sleep apnea (OSA) defined at an apnea-hypopnea index
(AHI)≥ 5 was a mean of 22%(range, 9-37%) in men and 17%(range, 4-50%) in women in …

Background CPAP is considered the therapy of choice for OSA, but the extent to which it can
reduce BP is still under debate. We undertook a systematic review and meta-analysis of …

Objectives Scoring laboratory polysomnography (PSG) data remains a manual task of
visually annotating 3 primary categories: sleep stages, sleep disordered breathing, and limb …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …

Rationale: Continuous positive airway pressure (CPAP) and mandibular advancement
device (MAD) therapy are commonly used to treat obstructive sleep apnea (OSA) …

Three recent randomized control trials (RCTs) found that treatment of obstructive sleep
apnea (OSA) with continuous positive airway pressure (CPAP) did not reduce rates of future …

Rationale: Primary treatment of obstructive sleep apnea can be accompanied by a
persistence of excessive sleepiness despite adherence. Furthermore, effectiveness of sleep …

Background Continuous positive airway pressure (CPAP) for symptomatic obstructive sleep
apnoea (OSA) improves sleepiness and reduces vascular risk, but such treatment for the …

Objective To assess the effect of continuous positive airway pressure (CPAP) on 24 hour
ambulatory blood pressure monitoring values in a large number of patients with untreated …

Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA)
allows for consolidation and determination of the key factors important for clinical …